None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients who consented to the subject consent form and human derived materials consent form ? Patients aged 19 years or older on the date of signing the consent form ? Patients with the ability to give written consent to voluntarily participate in this study ? Patients who can collect specimens through biopsy and surgical procedure ? A patient with histologically confirmed breast cancer or a patient who has cancer findings through imaging and undergoes a biopsy for pathological confirmation
Exclusion criteria
Exclusion criteria: ? Patients who do not understand or do not consent to written consent ? Patients who are unable to obtain sufficient specimens ? Patients who do not consent to genetic testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification and evaluation of individual genetic characteristics of breast cancer patients through whole genome analysis and observation items | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation evaluation between whole genome analysis results and genetic subtypes of cancer | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center